EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year
January 20, 2021 08:00 ET
|
EDAP TMS S.A.
Record HIFU revenue growth of 50% in the fourth quarter 2020 driven by the sale of eight HIFU devices sold during the quarter Achieved sequential quarterly revenue growth throughout 2020...
EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference
January 19, 2021 08:00 ET
|
EDAP TMS S.A.
LYON, France, January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski, President and CEO, will...
EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing HIFU to Radical Prostate Surgery
January 14, 2021 08:00 ET
|
EDAP TMS S.A.
Results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP) HIFU treatment also resulted in meaningful benefits in both urinary and...
EDAP Issues Letter to Shareholders
January 06, 2021 08:00 ET
|
EDAP TMS S.A.
Recaps progress made in 2020 notwithstanding the ongoing COVID-19 pandemic and previews anticipated 2021 milestones LYON, France, January 6, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”),...
EDAP to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event
January 05, 2021 08:00 ET
|
EDAP TMS S.A.
LYON, France, January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that it will participate in the 10th Annual LifeSci...
EDAP Announces End of the Year Focal One® Sales
December 30, 2020 08:00 ET
|
EDAP TMS S.A.
Among December deals closed, two major US institutions have purchased Focal OneUniversity of California, San Francisco Medical Center and Cleveland Clinic become latest to adopt Focal One high...
EDAP Announces Final U.S. 2021 Reimbursement Rules for High Intensity Focused Ultrasound (HIFU)
December 09, 2020 08:00 ET
|
EDAP TMS S.A.
Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the USPhysician reimbursement for...
EDAP Reports Third Quarter 2020 Results and Provides Operational Update
November 18, 2020 16:35 ET
|
EDAP TMS S.A.
Generated strongest total revenue quarter of 2020 Reported growth in HIFU procedure revenues year-over-year notwithstanding ongoing COVID-19 pandemicCompleted sales to renowned healthcare...
EDAP Announces Exclusive Distribution Agreement with Leading Italian Medical Device Distributor AB Medica
November 17, 2020 08:00 ET
|
EDAP TMS S.A.
Partnership further extends the availability of EDAP’s High Intensity Focused Ultrasound (HIFU) technology to one of the largest markets in Europe Complementary to AB Medica’s extensive product...
EDAP Announces Presentation at the Jefferies Virtual London Healthcare Conference
November 10, 2020 08:46 ET
|
EDAP TMS S.A.
LYON, France, November 10, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the Jefferies Virtual London...